Omada Health, Inc.OMDAEarnings & Financial Report
Nasdaq
OMDA Q3 2025 Key Financial Metrics
Revenue
$68.0M
Gross Profit
$45.1M
Operating Profit
$-2.5M
Net Profit
$-3.2M
Gross Margin
66.3%
Operating Margin
-3.7%
Net Margin
-4.7%
YoY Growth
49.5%
EPS
$-0.06
Financial Flow
Omada Health, Inc. Q3 2025 Financial Summary
Omada Health, Inc. reported revenue of $68.0M for Q3 2025, with a net profit of $-3.2M (-4.7% margin). Cost of goods sold was $23.0M, operating expenses totaled $47.6M.
Key Financial Metrics
| Total Revenue | $68.0M |
|---|---|
| Net Profit | $-3.2M |
| Gross Margin | 66.3% |
| Operating Margin | -3.7% |
| Report Period | Q3 2025 |
Income Statement
| Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Revenue | $41.2M | $45.5M | $61.4M | $68.0M |
| YoY Growth | N/A | N/A | 48.9% | 49.5% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Assets | N/A | N/A | $303.0M | $287.5M |
| Liabilities | N/A | N/A | $88.8M | $70.1M |
| Equity | $-373.4M | $-379.8M | $214.2M | $217.3M |
Cash Flow
| Q3 2025 | |
|---|---|
| Operating CF | $10.1M |